The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries have transformed how medicine is practiced.
The awardees are mid-career researchers who have significantly impacted the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.
The 13th annual Ross Prize in Molecular Medicine is awarded jointly to Drs. Carl June and Michel Sadelain for their pioneering work in developing CAR T-cell therapy for cancer treatment.
Dr. June’s and Sadelain’s complementary work has led to the groundbreaking form of personalized cancer immunotherapy that modifies T cells from a patient’s immune system with synthetic receptors called chimeric antigen receptors (CARs). These receptors enable them to recognize and selectively destroy cancer cells when infused back into the patient’s body. CAR T-cell technology has revolutionized how physicians treat leukemia, lymphoma, and multiple myeloma, and is now showing promise in treating autoimmune and infectious diseases.
Join us in celebrating Dr. June’s and Dr. Sadelain’s innovative, award-winning research on June 11th.
This hybrid symposium will include presentations from Dr. June and Dr. Sadelain on the integral facets of their work, plenary lectures, and in-person networking opportunities. Register today to participate in this incredible celebration of scientific innovation.
Sponsors
Presented By
This symposium is made possible by the generosity of Jack and Robin Ross with support from:
The New York Academy of Sciences found its current home with a move to 115 Broadway in May 2023. The building has its own unique history dating back more than a century.
Published March 23, 2026
By Nick Fetty
A 1906 shot of the Trinity and U.S. Realty Buildings. Image via University of Michigan Library Digital Collections.
The United States Realty Building | 115 Broadway | 2023-Present
The site of The New York Academy of Sciences’ current home at 115 Broadway has an intriguing history dating to the American Revolution.
Construction on the U.S. Realty Building (115 Broadway) was finished in 1907, two years after completion of the nearly identical Trinity Building (111 Broadway) directly to the south. The 21-story, steel-framed, Indiana limestone, Gothic-revival buildings were considered early examples of New York City skyscrapers. The two buildings were designed to complement the aesthetic of Trinity Church, immediately to the south.
Some accounts, such as from The New York Times’ Christopher Gray, dubbed the two buildings as the original “twin towers.” These buildings, which graced the city skyline during an era when the tallest structures were concentrated in Lower Manhattan, were designated New York City landmarks in 1988.
Both buildings were designed by Francis Kimball, the famous New York architect with projects such as the still standing Empire Building, 71 Broadway, (not to be confused with the Empire State Building), and the now-defunct Casino Theatre, 1404 Broadway and West 39th Street, to his name. An American by birth, Kimball was inspired by Gothic revival architecture while visiting London in the 1870s. He was dubbed “The Father of the Skyscraper” by The New York Times in 1917, two years prior to his death. Many of Kimball’s skyscrapers utilized a then-new engineering development known as “caissons,” which are retaining structures used when building bridges and the base of large buildings.
The two buildings include several impressive architectural features such as limestone gargoyles and brass dragons perched around the exteriors as well as double height basket-arched windows at the base of each. Each building has an entryway adorned with Sienna Marble and white statuary marble imported from Italy. The entryway’s high, arched ceilings and stained glass interior windows give the feel of a “European house of worship” while gilded grotesques – some smiling, some frowning – peer down on building tenants and guests as they wait for the elevator.
The History of the Site
The U.S. Realty Building is located approximately six blocks south of the Academy’s first home near Barclay and Broadway during the 19th century. At this time (1817), the City Hotel stood approximately where the U.S. Realty Building stands today. It was among the grandest hotels in the city during this era with more than “one hundred large and small parlours and lodging-rooms” as well as a concert/banquet hall.
Prior to City Hotel, the site was home to a tavern that served as a meeting spot for the Sons of Liberty in 1765 as they planned a resistance to the British Stamp Act. It was also the location for George Washington’s 1789 inaugural ball. Fast-forward two centuries, and the building makes an appearance in the music video for Jay-Z and Alicia Keys’s 2009 anthem “Empire State of Mind.”
The U.S. Realty Building, the Trinity Building, and the spire of Trinity Church can be seen around the 1:41 mark in the music video of “Empire State of Mind.” Screenshot via S. Carter Enterprises/YouTube.
The Academy moved into its new facility in May 2023. An Open House reception was hosted on Sept. 14, at which 200 scientists and science enthusiasts had the opportunity to tour the space. The Academy’s new home hosts dozens of Academy events (hybrid and in-person) throughout the year and is available for rent by the public.
“My hope is that we become not only the virtual go-to space but we actually become the physical go-to space where people think ‘this is the place where I can hang out, I can interact with really interesting, smart people, I can engage in conversations that reflect the Academy’s fundamental purpose,’” Academy President and CEO Nick Dirks said during the 2023 open house.
This is the final piece in an eleven-part series exploring the Academy’s past homes. Read:
Actors, a past president, and even a “world champion” racer. Here are six famous non-scientists with ties to The New York Academy of Sciences.
Published March 19, 2026
By Nick Fetty
For more than 200 years, the academy has prided itself on its egalitarian and democratic roots. Anyone with an interest, even curiosity, in science could become a member. This includes celebrities as well as those who wouldn’t be considered scientists in the traditional sense.
Here are six non-scientists with ties to the Academy, listed alphabetically.
Fernando Alonso, Formula One Racer
It’s not every day that a “world champion” visits the Academy. But that’s exactly what happened when two-time Formula One titlist Fernando Alonso visited in 2012.
Alonso gave a speech to motorheads and other attendees during an event at the Academy’s former office on the 40th floor of 7 World Trade Center. At this point in his career he was racing for Ferrari, the Italian luxury sports car manufacturer that dominates the world of F1 racing. Appropriate for a talk at the Academy, Alonso focused on the STEM aspects of racing and automotive performance.
“I think there is never enough technology,” he said, according to reporting from the London-based Daily Telegraph. “Technology is our motivation and the main goal for engineers and designers.”
The Spaniard won the world titles in 2005 and 2006 while racing for French-based Renault. He has since joined the Aston Martin Aramco Formula One Team and is geared up for the start of the 2026 race season. He’s driving a new car designed by British engineer Adrian Newey, “the most successful car designer in F1 history.”
The 2026 race season got underway earlier this month with the Qatar Airways Australian Grand Prix.
Salvador Dalí, Artist
Fellow Spaniard, artist Salvador Dalí, also has an Academy connection.
Part of the surrealistic art movement of the 20th century, Dalí was known for his “eccentric behavior and his eerie paintings.” His 1931 painting The Persistence of Memory depicts a realistic landscape with surreal melting clocks, a scene that a brain under the influence of hallucinogens might conjure up (see Aldous Huxley section below.)
The late Adnan Waly, PhD, a German-born nuclear physicist and longtime Academy member, recalled when the Spanish surrealist made a surprise appearance at an Academy event.
“I was at the Academy attending a lecture of the Nuclear Section. I found a seat in an empty row because not too many people were interested in nuclear physics at the time. The door opened, and in came a gentleman flanked by two gorgeous women. It was Salvadore Dalí with his moustache and his cane. He sat in my row with the ladies, and he put his cane up, two hands on the cane and his chin resting on it, as was his habit. He looked at the pictures that were presented,” Dr. Waly recalled.
“One of the pictures was of a cloud chamber — a photograph of particles moving apart from a center,” Dr. Waly continued. “Some time afterwards I saw a television program where Dalí was interviewed, and his latest painting was exactly what he had seen at the Academy, with tracks coming out from the center. ‘You don’t know what this is?’ Dalí said to the interviewer. ‘These are pimmesons.’ The lecture had been on the π meson.”
Dalí passed away in 1989 at the age of 84. Today the Academy continues its long, proud history of combining the arts and the sciences. This includes events with artists and providing space for works to be exhibited.
Michael J. Fox, Actor
Known for starring roles in 1980s classics like Back to the Future and Family Ties, Michael J. Fox’s acting career was forever changed by his Parkinson’s disease (PD) diagnosis at the age of 29.
Instead of sitting on the sidelines, Fox took an active role in advocating for the disease. In 2000, shortly after going public with his diagnosis, he founded the Michael J. Fox Foundation for Parkinson’s Research. To date, the organization has raised more than $2.5 billion to support research.
In addition to his advocacy and despite his condition, Fox continued to act. He voiced lead roles in multiple movies and has made various guest appearances on television. His appearance on HBO’s Curb Your Enthusiasm served as a chance to use humor to teach viewers about PD.
“It has long been recognized that humor can help those suffering from chronic conditions better cope with their diseases, and any chance to increase awareness of Parkinson’s disease among the general public is important,” Dr. Cheryl Waters of the Neurological Institute at Columbia University Medical Center told ABC News in 2011.
Though his condition has worsened to the point that he is now officially retired from acting, Fox remains optimistic that with adequately funded science a cure is possible.
“I know we’ve done a lot, but we haven’t cured Parkinson’s,” Fox told TIME magazine earlier this year. “I’m always pushing and never happy until we get this done. We’ve changed the way people think about the disease, and we know there’s an end, and we’ll find it.”
Aldous Huxley, Author
Aldous Huxley (seated, left) during a 1956 conference at the Academy.
The English-born writer and philosopher is perhaps best known for works like Brave New World (1932) and The Doors of Perception (1963). Though less known, Aldous Huxley is also tied to what’s believed to be the first public utterance of the term psychedelic.
Huxley befriended Humphry Osmond, a psychiatrist researching the therapeutic potential of substances like LSD in the 1950s. He was known to supply Huxley with hallucinogens like LSD and mescaline.
“Meanwhile, all that one can predict with any degree of certainty is that it will be necessary to reconsider and re-evaluate many of our traditional notions about ethics and religion, and many of our current views about the nature of the mind, in the context of the pharmacological revolution,” Huxley concluded. “It will be extremely disturbing; but it will also be enormous fun.”
Huxley passed away on November 4, 1963, the same day as fellow British writer C.S. Lewis, author of The Chronicles of Narnia (1950-1956). Both deaths were overshadowed by the assassination of U.S. president John F. Kennedy.
Appropriate for the man co-credited with coining the term psychedelic, Huxley had one dying wish. “At his request,” New York Magazine reported, “his wife shot him up with LSD a couple of hours before his end, and he tripped his way out of the world.”
Thomas Jefferson, 3rd President of the United States
Thomas Jefferson was a Founding Father and the third president of the United States.
“The botany of America is far from exhausted, its mineralogy is untouched, and its zoology totally mistaken. We have spent the prime of our lives in procuring your students the precious blessing of liberty. Let them spend theirs in showing that it is the great parent of science and of virtue, and that a nation will be great in both ways in proportion as it is free,” Jefferson wrote in a letter to the Harvard University president in the early 19th century.
While some of Jefferson’s views and actions would without doubt be considered insensitive (to put it mildly) today, he nonetheless played a significant role in shaping the United States, the Academy, and science broadly.
Christohpher Reeve, Actor
Like fellow actor Michael J. Fox, Christopher Reeve’s career began on the silver screen before he became a science advocate.
Born in NYC, Reeve studied at Cornell University and Julliard, before getting his breakthrough as Superman in the eponymous 1978 film. He went on to play the red-and-blue-decked DC Comics superhero in the three subsequent films in the 1980s.
At six-foot-four with an athletic build, Reeve physically embodied the part of a superhero. He even “performed many of his [own] stunts, including dangerous ‘flying’ exercises,” according to a 2004 CNN article. But Reeve’s life took a drastic and unexpected turn when a 1995 horse-riding accident paralyzed him from the neck down.
Following the accident, Reeve required a wheelchair to move and a respirator to breathe. Around this era, stem cells and cloning were emerging as potential, albeit ethically controversial in some circles, methods for repairing damaged tissues and organs. The conservative George W. Bush administration at this time opposed federal funding for embryonic stem cell research.
During an event at the Academy in May 2002, Reeve, an advocate of stem cell research, debated James Kelly, who presented an apprehensive take on the new treatment. Kelly, who was paralyzed in a car accident, felt that “using human eggs to treat injury and disease is too far in the future, too costly, and would divert funding from more promising research,” according to a 2002 article from the Knight Ridder news service.
Reeve retorted that “therapeutic cloning is different from reproductive cloning.” He suggested that U.S. policy around the matter should take a “strictly regulated” approach like England. Despite the at-times contentious debate, events like this highlight the need for earnest discussions from various viewpoints, to advance science.
Christopher Reeve passed away just two years after the event, at the age of 54.
To attend, click the “Register” button at the time of the presentation. It will take you directly to the Zoom call.
Welcome and Introductions: 11:30 AM to 11:45 AM
Main Presentation: 11:45 AM to 2:30 PM
Our April Program has four parts. The overall moderator is our president, Clif Hotvedt.
1. REVIEW OF PROGRAM GROWTH FOR THE PAST 12 MONTHS, AND PLANNING FOR NEXT SEASON
We will introduce our resourceful Lyceum Planning Team: Chairman, Phil Apruzzese, Bill Rosser (VP), Stuart Kurtz, Uldis Blukis, and Herb Klitzner. Each person on this team has given numerous talks to Lyceum over the years. In addition, together, the team has developed new concepts for talks, such as our successful periodic “Making of a Scientist” series and our annual “Nobel Prize Winners” sensitive profiles.
2. EVOLUTION AND THE RISE OF CREATIVE POTENTIAL
We will discuss and develop our scheduled May 4 Talk on the topic of Evolution of Creativity, Resilience, and “Anti-Fragility,” producing unusual individuals of different kinds to truly rescue society in times of crisis, when conventional tools fail in the face of a new challenge. Bill Rosser will organize and lead the discussion. Bill is our Lyceum VP and was a senior executive at Gartner Group, the leading market research firm in emerging computer technologies.
As part of our discussion, to help us understand this process of rescue, Stuart Kurtz,world-traveledchemical engineer and interpreter of the science endeavor will share with us an important example from the History of Science – the growing “Nitrogen Fertilization Shortage” from the late 1800s to 1913 just before the opening of WW 1.
In addition, Jean Smith, a planner at the Science Discussion Network of the Unitarian Universalist Congregation at Shelter Rock, in Manhasset, Long Island, will describe her unique experience in resourcefully applying scientifically based deeply creative techniques to first understand and then solve a serious infection that had been diagnosed as untreatable. As part of her process of evolving a successful treatment for herself, she created a Facebook group of eventually 8,000 people whose conditions resembled her own, along one dimension or another, helping them to move forward in their own lives.
3. OTHER NEW PROGRAM HIGHLIGHTS
We will also examine three other pivotal subject area clusters, listed below.To explore possibilities, we will sample one specific topic to focus on next season from each of the three clusters:
BioMed/Pharma/Physical Therapy (PT).
AI, Math, Values, Human Development, Psychology, the Science of Aesthetics, and the Designing of Future AI-Customized Tools.
History of Science, and the Connectedness of Science and Culture.
4. OPEN DISCUSSION
At the last part of our meeting, we will open up the discussion to the audience for further comments and suggestions. Please join us with your ideas in this special future-oriented program discussion.
Mitochondrial Health and Healthspan: Brain Metabolism and Bioenergetics will bring together leading researchers and clinician-scientists to explore the central role of mitochondria in brain function, resilience, and aging. Once viewed primarily as cellular powerhouses, mitochondria are now understood to regulate signaling, inflammation, gene expression, and neuroplasticity. Their influence spans development, stress adaptation, metabolic regulation, and neurodegenerative disease, positioning mitochondrial biology at the forefront of efforts to extend healthspan and preserve cognitive vitality.
The symposium will highlight advances across three interconnected themes. Mitochondrial Genetics and Cellular Signaling in Brain Health will examine how mitochondrial DNA variation and bioenergetic function shape neural performance and disease risk. Mitochondrial Psychobiology: Stress, Development, and Neuroplasticity will explore how stress and early life experience influence mitochondrial dynamics and long-term mental health. Metabolic Psychiatry and Mitochondrial Therapeutics: From Diet to Drug Development will focus on emerging nutritional, metabolic, and pharmacologic strategies to target mitochondrial pathways implicated in psychiatric conditions.
Through keynote and plenary presentations, participants will gain insight into mechanisms linking mitochondrial dysfunction to cognitive decline, mood disorders, neurodevelopmental conditions, and neurodegeneration. Emphasis will be placed on translational opportunities, including biomarkers and precision interventions that move from discovery to therapeutics. Join us on November 11, 2026, for a focused and forward-looking discussion at the intersection of bioenergetics, brain science, and healthy aging.
The Dr. Paul Janssen Award Symposium celebrated the groundbreaking achievements of Dr. Anthony “Tony” Hunter, PhD, American Cancer Society Professor and Renato Dulbecco Chair at the Salk Institute for Biological Studies in La Jolla, California. This symposium brought together leading voices in cancer research and biomedical innovation to honor Dr. Hunter’s pioneering work and explore its profound impact on modern science and medicine.
To attend, click the “Register” button at the time of the presentation. It will take you directly to the Zoom call.
Welcome and Introductions: 11:30 AM to 11:45 AM
Main Presentation: 11:45 AM to 2:30 PM
Biological Rhythms, the Secret Language of your Vital Signs
Daniel Forger
From the firing of neurons in a fraction of a second to the monthly cycle of ovulation to a seasonal shift in sleep patterns, the human body runs on rhythms—all more knowable now than ever, thanks to wearables. Making sense, and making use, of these signals is something else, and this is precisely what Daniel Forger explains in his book Biological Rhythms, which will be the focus of our discussion. Sorting through a plethora of data gathered over the past decade, this practical, user-friendly book gives readers the tools for reading and interpreting the rhythms that regulate physiological processes as varied and critical as sleep, brain activity, heart rate, hormone secretion, metabolism, and temperature. Once translated, the language of biological rhythms can be used to improve health and productivity, by athletes, travelers, and shift workers, sufferers of fatigue or sleep disorders, or those wishing to lose weight, monitor infection, or time fertility, in short, anyone with an interest in reading and understanding the body’s vital signs.
Speaker
Daniel B. Forger is Robert W. and Lynn H. Browne Professor of Science, Professor of Mathematics, and Research Professor of Computational Medicine and Bioinformatics at the University of Michigan, Ann Arbor. He directs the Michigan Center for Applied and Interdisciplinary Mathematics and is the CSO of Arcascope. Hundreds of thousands of people have used his apps and algorithms for scoring sleep and circadian rhythms, predicting mood and fatigue, and analyzing time series data. Dr. Forger was also active in the Junior Academy of the NY Academy of Sciences when he attended Stuyvesant High School.
Join experts for a day of discovery and dialogue about how understanding the neuroscience of kindness can shape a healthier, more connected world.
Published February 19, 2026
By Nick Fetty
In an era of divisiveness and polarization, a little kindness and empathy can go a long way. But what happens in the brain when a person acts with compassion? And what impact does this have on individuals and society more broadly?
These questions and more will be explored during the Neuroscience of Kindness conference on March 3. This one-day event, hosted at West End Labs in New York City and also streamed virtually, will examine:
How kindness develops across the lifespan
The evolutionary roots of cooperation, and
The measurable effects of compassion and altruism on physical and mental health
The conference will bring together leading researchers, clinicians, and public health experts to explore the biological, psychological, and social foundations of prosocial behavior.
Leading Experts Presenting Cutting-Edge Research
The event’s keynote address will be delivered by Richard J. Davidson, PhD. Dr. Davidson is the William James and Vilas Research Professor of Psychology and Psychiatry as well as Founder and Director of the Center for Healthy Minds at the University of Wisconsin-Madison. His work focuses on the neural bases of emotion and emotional style and methods to promote human flourishing including meditation and related contemplative practices.
Participants will also discuss practical strategies for cultivating kindness in communities, workplaces, and institutions. And how doing so may represent an urgent public health priority. Networking breaks will take place between sessions and lunch will be provided.
The conference is presented by the University of Wisconsin-Madison’s Center for Healthy Minds, Humin, West End Labs, and The New York Academy of Sciences. Gold-level sponsor support was provided by Nurture Connection.
While the desirability of change in the health care system is well accepted, how it is to be achieved is not. One flashpoint has been the involvement of private capital firms in healthcare. In theory, private equity brings capital and discipline to firms in a manner that should be helpful to the healthcare industry. But popular accounts and academic studies have raised troubling questions.
As technology-driven advancements and clinical innovation accelerate the evolution of the life sciences, can PE play a constructive role to enable life sciences firms to better position themselves for success in a competitive and rapidly evolving environment? Or are the temptations to profit at the expense of the customer too great in these settings?
This session will explore the evidence about these important and controversial issues. In particular, this program will focus on two issues:
How advances in information and communication technologies, which have transformed everything from urban transport to payments to navigation, can address the effectiveness of medical delivery, and the role of venture capital in facilitating this transformation.
The role of private capital in financing the “white spaces” in the delivery of medical services: e.g., the areas where consumers are underserved, whether geographic, demographic, or class of care (e.g., primary care).
Series Moderator
Josh Lerner
The Jacob H. Schiff Professor, Harvard Business School; Director, Private Capital Research Institute
Panelists
Abrar Mir
Co-founder and Managing Partner, Quadria Capital
Charles Ruprecht
Principal, GHO Capital
Kevin Tracey
Karches Family Distinguished Chair in Medical Research, The Feinstein Institutes for Medical Research
Paula Volent
VP & Chief Investment Officer, The Rockefeller University
Sponsors
Series Sponsor
Presented By
Pricing
All: Free
About the Series
The “Private Capital and Discovery: Strategic Investing in Scientific Innovation” series is brought to you by The New York Academy of Sciences and The Private Capital Research Institute. Through expert panels and thought-provoking discussions, the series examines how private equity is uniquely positioned to drive transformative advancements—while also exploring the ethical and strategic dilemmas that can arise when financial incentives influence the trajectory of science. Learn more about the series.
This year’s scientific luminaries include John Sexton from New York University, Maria Gotsch from the Partnership Fund for New York City, Dr. Sanjay Gupta from CNN, and Josh Lerner from Harvard Business School.
New York, NY (January 28, 2026) – A new cohort of changemakers will be recognized for their innovation and discovery during The New York Academy of Sciences’ 2026 Spring Soirée hosted by Academy President and CEO Nicholas B. Dirks.
The Academy’s second annual Spring Soirée will take place on April 21 at the University Club of New York (One West 54th Street). The reception will begin at 6 p.m. followed by dinner and a program at 7 p.m. Seema Kumar, CEO of Cure and a member of the Academy’s Board of Governors, will serve as Dinner Chair.
As is tradition, the Soirée is an opportunity to recognize pioneering changemakers whose work exemplifies the Academy’s mission of advancing science for the benefit of society. This year’s awardees include:
Visionary Award:Maria Gotsch, MBA, President and Chief Executive Officer of the Partnership Fund for New York City
Science Communicator Award:Sanjay Gupta, MD, Chief Medical Correspondent for CNN
Trailblazer Award:John Sexton, PhD, President Emeritus of NYU and Chair Emeritus of the Academy’s Board of Governors
Constellation Award:Josh Lerner, PhD, Jacob H. Schiff Professor at Harvard Business School and Co-Director of the HBS Private Capital Project
STEM Teacher of the Year:To be announced
STEM Mentor of the Year:To be announced
The Soirée also serves as the Academy’s premier fundraising event of the year. Proceeds will help to support future Academy programming. From individuals and nonprofits to corporations and academic institutions, the Academy is seeking sponsors at a range of different funding levels.
Soirée Underwriter – $100,000
Mission Partner – $50,000
Benefactor – $25,000
Individual Ticket – $2,000
The Soirée promises to be an inspiring evening, filled with engaging conversations and captivating stories of scientific triumph.
“This will be a magical evening in which we offer the opportunity to celebrate and engage some of the most important champions of scientific progress, collaboration, and commitment to the public good,” said Nicholas Dirks. “Join us – along with representatives from world-class companies, top universities and research institutes, philanthropic organizations, and both the public and private sector – as together we honor the exceptional achievements of accomplished leaders who do so much to expand the frontiers of knowledge and shape the future of science.”